(Q32062993)

English

Cerivastatin prevents tumor necrosis factor-alpha-induced downregulation of endothelial nitric oxide synthase: role of endothelial cytosolic proteins

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

6 July 2017

Cerivastatin prevents tumor necrosis factor-alpha-induced downregulation of endothelial nitric oxide synthase: role of endothelial cytosolic proteins (English)

1 reference

Europe PubMed Central

6 July 2017

0 references

author name string

González-Fernández F

1

1 reference

Europe PubMed Central

6 July 2017

Jiménez A

2

1 reference

Europe PubMed Central

6 July 2017

López-Blaya A

3

1 reference

Europe PubMed Central

6 July 2017

Velasco S

4

1 reference

Europe PubMed Central

6 July 2017

Arriero MM

5

1 reference

Europe PubMed Central

6 July 2017

Celdrán A

6

1 reference

Europe PubMed Central

6 July 2017

Rico L

7

1 reference

Europe PubMed Central

6 July 2017

Farré J

8

1 reference

Europe PubMed Central

6 July 2017

Casado S

9

1 reference

Europe PubMed Central

6 July 2017

López-Farré A

10

1 reference

Europe PubMed Central

6 July 2017

publication date

1 March 2001

1 reference

Europe PubMed Central

6 July 2017

Atherosclerosis

1 reference

Europe PubMed Central

6 July 2017

155

1 reference

Europe PubMed Central

6 July 2017

1

1 reference

Europe PubMed Central

6 July 2017

61-70

1 reference

Europe PubMed Central

6 July 2017

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900535-9

7 January 2021

Reduction in cardiovascular events during pravastatin therapy. Pooled analysis of clinical events of the Pravastatin Atherosclerosis Intervention Program

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900535-9

7 January 2021

Effect of partial ileal bypass surgery on mortality and morbidity from coronary heart disease in patients with hypercholesterolemia. Report of the Program on the Surgical Control of the Hyperlipidemias (POSCH)

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900535-9

7 January 2021

Lipid lowering and plaque regression. New insights into prevention of plaque disruption and clinical events in coronary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900535-9

7 January 2021

Reduction in serum cholesterol with pravastatin improves endothelium-dependent coronary vasomotion in patients with hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900535-9

7 January 2021

Beneficial effects of cholesterol-lowering therapy on the coronary endothelium in patients with coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900535-9

7 January 2021

From isolated vessels to the catheterization laboratory. Studies of endothelial function in the coronary circulation of humans

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900535-9

7 January 2021

The L-arginine-nitric oxide pathway

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900535-9

7 January 2021

The nitric oxide synthase family of proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900535-9

7 January 2021

Endothelium-mediated coronary blood flow modulation in humans. Effects of age, atherosclerosis, hypercholesterolemia, and hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900535-9

7 January 2021

Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900535-9

7 January 2021

Cardiovascular effects of acute hypercholesterolemia in rabbits. Reversal with lovastatin treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900535-9

7 January 2021

Chronic exercise in dogs increases coronary vascular nitric oxide production and endothelial cell nitric oxide synthase gene expression

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900535-9

7 January 2021

Tumor necrosis factor downregulates an endothelial nitric oxide synthase mRNA by shortening its half-life

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900535-9

7 January 2021

Lack of role for nitric oxide (NO) in the selective destabilization of endothelial NO synthase mRNA by tumor necrosis factor-alpha

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900535-9

7 January 2021

Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900535-9

7 January 2021

Pravastatin sodium activates endothelial nitric oxide synthase independent of its cholesterol-lowering actions

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900535-9

7 January 2021

Cytoplasmic regulation of mRNA function: the importance of the 3' untranslated region

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900535-9

7 January 2021

Endothelial cytosolic proteins bind to the 3' untranslated region of endothelial nitric oxide synthase mRNA: regulation by tumor necrosis factor alpha

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900535-9

7 January 2021

Tumor necrosis factor-alpha in human arterial wall with atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900535-9

7 January 2021

Expression of constitutive and inducible nitric oxide synthases in the vascular wall of young and aging rats

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900535-9

7 January 2021

Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900535-9

7 January 2021

Aspirin inhibits inducible nitric oxide synthase expression and tumour necrosis factor-alpha release by cultured smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900535-9

7 January 2021

Aspirin inhibits nuclear factor-kappa B mobilization and monocyte adhesion in stimulated human endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900535-9

7 January 2021

Antioxidants inhibit monocyte adhesion by suppressing nuclear factor-kappa B mobilization and induction of vascular cell adhesion molecule-1 in endothelial cells stimulated to generate radicals

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900535-9

7 January 2021

Oxidized low-density lipoprotein decreases the expression of endothelial nitric oxide synthase

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900535-9

7 January 2021

Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900535-9

7 January 2021

The I kappa B proteins: multifunctional regulators of Rel/NF-kappa B transcription factors

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900535-9

7 January 2021

Lovastatin inhibits lipopolysaccharide-induced NF-kappaB activation in human mesangial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900535-9

7 January 2021

Simvastatin, an HMG-coenzyme A reductase inhibitor, improves endothelial function within 1 month

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900535-9

7 January 2021

Effect of acetylcholine on the highly stenotic coronary artery: difference between the constrictor response of the infarct-related coronary artery and that of the noninfarct-related artery

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900535-9

7 January 2021

Vasoreactivity of the culprit lesion in unstable angina

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900535-9

7 January 2021

Effect of cerivastatin sodium, a new inhibitor of HMG-CoA reductase, on plasma lipid levels, progression of atherosclerosis, and the lesional composition in the plaques of WHHL rabbits

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900535-9

7 January 2021

Identifiers

10.1016/S0021-9150(00)00535-9

1 reference

Europe PubMed Central

6 July 2017

1 reference

Europe PubMed Central

6 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q32062993&oldid=1967278360"